Log in to save to my catalogue

Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairme...

Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairme...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8505254

Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment

About this item

Full title

Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment

Publisher

London: Nature Publishing Group UK

Journal title

Molecular psychiatry, 2021-07, Vol.26 (7), p.3625-3633

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Angelman Syndrome (AS) is a severe neurodevelopmental disorder due to impaired expression of
UBE3A
in neurons. There are several genetic mechanisms that impair
UBE3A
expression, but they differ in how neighboring genes on chromosome 15 at 15q11–q13 are affected. There is evidence that different genetic subtypes present with different cl...

Alternative Titles

Full title

Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8505254

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8505254

Other Identifiers

ISSN

1359-4184

E-ISSN

1476-5578

DOI

10.1038/s41380-020-0858-6

How to access this item